Conference Coverage: ASCO GI 2024 Highlights

Expert perspectives and strategic insights on the latest therapeutic developments in GI cancer treatment from the 2024 ASCO GI Cancers Symposium, and implications on individualized clinical decision-making

January 24, 2024
Purchase Report

FACULTY CHAIR

John Marshall, MD

Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Faculty Members

Tanios Bekaii-Saab, MD, FACP
Mayo Clinic, Phoenix, AZ, USA

Sunnie Kim, MD
University of Colorado Cancer Center, Aurora, CO, USA

Reetu Mukherji, MD
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

David H. Ilson, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Dirk Arnold, MD, PhD
Asklepios Tumor Center, University of Hamburg, Germany

Eric Van Cutsem, MD, PhD
University Hospitals Gasthuisberg, University of Leuven, Belgium

Fotios Loupakis, MD, PhD
Veneto Institute of Oncology, Padua, Italy

Sample Report

Start discovering the insights

View Report

KEY TAKEAWAYS AND STRATEGIC INSIGHTS

  • Colorectal Cancer – Systemic Therapy
  • Colorectal Cancer – Biomarkers
  • Hepatocellular Carcinoma
  • Esophageal Cancers
  • Gastric and Gastroesophageal Junction (GEJ) Cancers
  • Pancreatic Cancer and Biliary Tract Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.